Raymond James, Third Harmonic

Raymond James Downgrades Third Harmonic Bio (THRD)
Fintel reports that on February 11, 2025, Raymond James downgraded their outlook for Third Harmonic Bio (NasdaqGM:THRD) from Outperform to Market Perform. Analyst Price Forecast Suggests 433.54% Upside As of January 29,
Morgan Stanley, Raymond James target new assets in 2025
The next CEO of Raymond James talks about how private equity ownership has made for some difficult marriages in wealth management, while a Morgan Stanley exec says asset outflows were unusually high last year.
Raymond James downgrades Third Harmonic Bio on uncertainty for only asset
As previously reported, Raymond James downgraded Third Harmonic Bio (THRD) to Market Perform from Outperform and removed the firm’s prior $18
Harmonic price target lowered to $12 from $14 at Raymond James
Raymond James lowered the firm’s price target on Harmonic (HLIT) to $12 from $14 and keeps an Outperform rating on the shares. Harmonic’s Q4
Third Harmonic stock rating cut by Raymond James
James made a notable change in their assessment of Third Harmonic (NASDAQ:HLIT) Bio (NASDAQ:THRD), downgrading the biotechnology company's stock rating from Outperform to Market Perform. According to InvestingPro data,
Third Harmonic Bio downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded Third Harmonic Bio (THRD) to Market Perform from Outperform. Published first on TheFly – the ultimate source for
Raymond James Downgrades ConocoPhillips (COP)
Fintel reports that on February 10, 2025, Raymond James downgraded their outlook for ConocoPhillips (NYSE:COP) from Strong Buy to Outperform. Analyst Price Forecast Suggests 37.63% Upside As of January 28,
GovCon Wire20h
Raymond James’ Andy McEnroe on Post-Election GovTech Market
Uncover why the promises of the second Trump administration have contractors concerned about spending and acquisition funding ...
Raymond James Has Negative Outlook of Ero Copper Q3 Earnings
Analysts at Raymond James reduced their Q3 2025 EPS estimates for shares of Ero Copper in a research note issued to investors ...
Raymond James Becomes Latest Financial Firm to Dial Back on Reporting Advisor Head Count
Following similar moves by other large firms, Raymond James says quarterly advisor counts aren’t the most meaningful measure ...
Palantir or AMD: Raymond James Chooses the Better AI Stock to Buy After Earnings
January finished with an earthquake in the tech world, when the Chinese startup DeepSeek released its new AI assistant – and ...
Trump tariffs signal desire to use levies to help pay for tax cuts - Raymond James
Investing.com - U.S. President Donald Trump's move to impose new tariffs on steel and aluminum imports points to a drive by ...
Raymond James: Strong Balance Sheet And Cash Economics Are In The Price
Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...
Raymond James Financial (RJF) Gets a Buy from Argus Research
In a report released on February 7, Kevin Heal from Argus Research maintained a Buy rating on Raymond James Financial (RJF – Research Report).
InvestmentNews5d
LPL, Raymond James boost advisor ranks anew
LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...
Raymond James lifts USAC stock target to $30; maintains outperform
James analyst James Rollyson updated his outlook on USA Compression Partners LP (NYSE:USAC), raising the firm's price target on the stock to $30.00, up from the previous $27.00, while reiterating an ...